🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
Status
Completed
Location
Ospedale San Raffaele
Start Date
2018-06-18
Trial ID
NCT03434704
This study is being done to test a transplant method that may have fewer si...
Status
Suspended
Location
St. Jude Children's Research Hospital
Start Date
2020-04-30
Trial ID
NCT04362293
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
Background: Peripheral blood stem cell transplantation procedures are used...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2017-04-06
Trial ID
NCT03077542
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605
Background: Blood cancers (such as leukemias or lymphomas) often do not re...
Status
Recruiting
Location
City of Hope
Start Date
2022-11-18
Trial ID
NCT05436418
The primary objective of this study is to improve the 2-year progression-fr...
Status
Recruiting
Location
Aflac Cancer & Blood Disorders Centers
Start Date
2020-09-16
Trial ID
NCT04469530
Treatments Being Tested
Background: CGD causes infections and inflammation. The only cure currentl...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-10-28
Trial ID
NCT03910452
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-05-15
Trial ID
NCT02722668
Treatments Being Tested
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474